I paid $27 extra for expedited shipping but I pretty much received the items in the same amount of time as if I did regular shipping which is typically 3-4 weeks. I received my items in 26 days which is 3 1/2 weeks. Other than that it’s fine. I will not pay for expedited shipping next time.
Product Usage: This product is intended for research purposes only.
All product information available on this website is for educational purposes only. Any form of bodily introduction into humans or animals is strictly prohibited by law. This product should only be handled by licensed and qualified professionals. It is not a drug, food, or cosmetic, and must not be misbranded, misused, or mislabeled as such.
Survodutide
Survodutide is a once-weekly dual glucagon and GLP-1 receptor agonist being investigated for obesity, metabolic disease, and metabolic dysfunction-associated steatohepatitis (MASH). Clinical trials have reported substantial body-weight reductions alongside metabolic and liver-related improvements.
During our packaging transition, you may receive products with either our previous or updated label. Rest assured, the formulation, purity and quality remain exactly the same as per our standards.
- Credit card
- Bank transfer (instant SEPA)
- Bank transfer (ACH)
- Wise
- Revolut
- Zelle
- Remitly
- Western Union
- Chime
- Others
-25% on everything – until October 31
25% off regular prices, replacing other product sales. Only the crypto payment discount can be combined.
Overview
Survodutide is a once-weekly dual glucagon and GLP-1 receptor agonist being investigated for obesity, metabolic disease, and metabolic dysfunction-associated steatohepatitis (MASH). Clinical trials have reported substantial body-weight reductions alongside metabolic and liver-related improvements.
Survodutide activates both GLP-1 and glucagon receptors. Phase 2 research has evaluated it in adults with obesity and in people with MASH and liver fibrosis, with studies examining body weight, liver fat, fibrosis, glucose regulation, and other metabolic markers.
How It Works
GLP-1 receptor activation influences appetite and glucose regulation, while glucagon receptor activation affects energy metabolism and lipid handling. Survodutide combines these two signals into a single dual-action molecule.
References
- le Roux CW, Steen O, Lucas KJ, et al. Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial. Lancet Diabetes & Endocrinology. 2024;12(3):162-173. PMID: 38330987. PubMed
- Sanyal AJ, Bedossa P, Fraessdorf M, et al. A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis. New England Journal of Medicine. 2024. PMID: 38847460. PubMed
BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.
Customer Reviews (6)
Fast delivery, great product! Just order before you run out.
I’m very happy with the product. The quality is excellent, and delivery was prompt.
Our lab's research outcomes exceeded what we expected. Really happy with the fast turnaround times, the chemical quality is top notch. I will definitely be back.
Absolutely thrilled with the secure packaging and it's an exceptionally pure batch. Our research results have been outstanding. Highly satisfy and will return.
Great experience with the super fast shipping, purity exceeded my expectations. My laboratory research results exceeded expectations. Will buy again.